S&P 500   3,369.73 (-0.48%)
DOW   29,192.34 (-0.53%)
QQQ   234.52 (-1.04%)
AAPL   319.93 (-1.14%)
FB   214.53 (-1.36%)
MSFT   184.18 (-1.66%)
GOOGL   1,514.17 (-0.70%)
AMZN   2,150.14 (-0.93%)
CGC   22.25 (+2.20%)
NVDA   309.22 (-1.74%)
MU   58.85 (-1.92%)
GE   12.52 (-0.71%)
TSLA   897.29 (-2.19%)
AMD   57.11 (-3.04%)
T   38.59 (+0.39%)
ACB   1.68 (-1.75%)
F   8.04 (+0.50%)
PRI   136.42 (+0.54%)
BAC   34.79 (+0.20%)
DIS   140.28 (-0.73%)
GILD   66.94 (-0.61%)
S&P 500   3,369.73 (-0.48%)
DOW   29,192.34 (-0.53%)
QQQ   234.52 (-1.04%)
AAPL   319.93 (-1.14%)
FB   214.53 (-1.36%)
MSFT   184.18 (-1.66%)
GOOGL   1,514.17 (-0.70%)
AMZN   2,150.14 (-0.93%)
CGC   22.25 (+2.20%)
NVDA   309.22 (-1.74%)
MU   58.85 (-1.92%)
GE   12.52 (-0.71%)
TSLA   897.29 (-2.19%)
AMD   57.11 (-3.04%)
T   38.59 (+0.39%)
ACB   1.68 (-1.75%)
F   8.04 (+0.50%)
PRI   136.42 (+0.54%)
BAC   34.79 (+0.20%)
DIS   140.28 (-0.73%)
GILD   66.94 (-0.61%)
S&P 500   3,369.73 (-0.48%)
DOW   29,192.34 (-0.53%)
QQQ   234.52 (-1.04%)
AAPL   319.93 (-1.14%)
FB   214.53 (-1.36%)
MSFT   184.18 (-1.66%)
GOOGL   1,514.17 (-0.70%)
AMZN   2,150.14 (-0.93%)
CGC   22.25 (+2.20%)
NVDA   309.22 (-1.74%)
MU   58.85 (-1.92%)
GE   12.52 (-0.71%)
TSLA   897.29 (-2.19%)
AMD   57.11 (-3.04%)
T   38.59 (+0.39%)
ACB   1.68 (-1.75%)
F   8.04 (+0.50%)
PRI   136.42 (+0.54%)
BAC   34.79 (+0.20%)
DIS   140.28 (-0.73%)
GILD   66.94 (-0.61%)
S&P 500   3,369.73 (-0.48%)
DOW   29,192.34 (-0.53%)
QQQ   234.52 (-1.04%)
AAPL   319.93 (-1.14%)
FB   214.53 (-1.36%)
MSFT   184.18 (-1.66%)
GOOGL   1,514.17 (-0.70%)
AMZN   2,150.14 (-0.93%)
CGC   22.25 (+2.20%)
NVDA   309.22 (-1.74%)
MU   58.85 (-1.92%)
GE   12.52 (-0.71%)
TSLA   897.29 (-2.19%)
AMD   57.11 (-3.04%)
T   38.59 (+0.39%)
ACB   1.68 (-1.75%)
F   8.04 (+0.50%)
PRI   136.42 (+0.54%)
BAC   34.79 (+0.20%)
DIS   140.28 (-0.73%)
GILD   66.94 (-0.61%)
Log in

LON:BXP - BEXIMCO PHARMAC/S GDR REGS Share Price, Forecast & News

GBX 43.70
0.00 (0.00 %)
(As of 02/20/2020 03:54 PM ET)
Today's Range
43
Now: GBX 43.70
43.90
50-Day Range
38.50
MA: GBX 42.06
46
52-Week Range
34.10
Now: GBX 43.70
51
Volume133,520 shs
Average Volume35,555 shs
Market Capitalization£177.23 million
P/E RatioN/A
Dividend Yield3.23%
BetaN/A
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and active pharmaceutical ingredients in Bangladesh. The company offers allergic disorder, analgesic and antipyretic, anti-infective, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, muscloskeletal, oncology, respiratory, skin care, vitamin and mineral supplement, oral contraceptive, anti-histamine, anti-fibrinolytic, women's health, and other products. Read More…

Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+880-2-58611001

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees4,200
Market Cap£177.23 million
Next Earnings DateN/A
OptionableOptionable

Receive BXP News and Ratings via Email

Sign-up to receive the latest news and ratings for BXP and its competitors with MarketBeat's FREE daily newsletter.


BEXIMCO PHARMAC/S GDR REGS (LON:BXP) Frequently Asked Questions

What is BEXIMCO PHARMAC/S GDR REGS's stock symbol?

BEXIMCO PHARMAC/S GDR REGS trades on the London Stock Exchange (LON) under the ticker symbol "BXP."

Has BEXIMCO PHARMAC/S GDR REGS been receiving favorable news coverage?

Headlines about BXP stock have trended extremely negative on Thursday, InfoTrie Sentiment reports. The research firm ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. BEXIMCO PHARMAC/S GDR REGS earned a daily sentiment score of -4.3 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for BEXIMCO PHARMAC/S GDR REGS.

Who are some of BEXIMCO PHARMAC/S GDR REGS's key competitors?

Who are BEXIMCO PHARMAC/S GDR REGS's key executives?

BEXIMCO PHARMAC/S GDR REGS's management team includes the folowing people:
  • Mr. Nazmul Hassan MP, MD & Director
  • Mr. Ali Nawaz, Chief Fin. Officer
  • Mr. Rabbur Reza, Chief Operating Officer
  • Mr. Jamal Ahmed Choudhury, Exec. Director of Accounts & Fin.
  • Mr. M. A. Arshad Bhuiyan, Deputy Gen. Mang. of HR

How do I buy shares of BEXIMCO PHARMAC/S GDR REGS?

Shares of BXP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is BEXIMCO PHARMAC/S GDR REGS's stock price today?

One share of BXP stock can currently be purchased for approximately GBX 43.70.

How big of a company is BEXIMCO PHARMAC/S GDR REGS?

BEXIMCO PHARMAC/S GDR REGS has a market capitalization of £177.23 million. BEXIMCO PHARMAC/S GDR REGS employs 4,200 workers across the globe.View Additional Information About BEXIMCO PHARMAC/S GDR REGS.

What is BEXIMCO PHARMAC/S GDR REGS's official website?

The official website for BEXIMCO PHARMAC/S GDR REGS is http://www.beximco-pharma.com/.

How can I contact BEXIMCO PHARMAC/S GDR REGS?

BEXIMCO PHARMAC/S GDR REGS's mailing address is 19 Dhanmondi R/A, Road No. 7, DHAKA, 1205, Bangladesh. The company can be reached via phone at +880-2-58611001.


MarketBeat Community Rating for BEXIMCO PHARMAC/S GDR REGS (LON BXP)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  106 (Vote Outperform)
Underperform Votes:  117 (Vote Underperform)
Total Votes:  223
MarketBeat's community ratings are surveys of what our community members think about BEXIMCO PHARMAC/S GDR REGS and other stocks. Vote "Outperform" if you believe BXP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BXP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/20/2020 by MarketBeat.com Staff

Featured Article: Do You Need a Fiduciary?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel